Statistics
Publications
2
Citations
60
H-Index
2
Active since
2011
Affiliations
Inserm(Current)
Hervé Roudot is an author at Inserm specializing in hematologic malignancy therapy, dna damage checkpoint signaling, and hematologic malignancy pharmacotherapy.
Publications per year
2011–2017
2
2
Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia
Sylvain Thépot, Élodie Lainey, Thomas Cluzeau et al. · Cell Cycle · 2011 · 48 citations · Full text
Medicine, Oncology, Pharmacology +17
1–2 of 2